TY  - JOUR
AU  - Koutsoukos, Konstantinos
AU  - Bamias, Aristotelis
AU  - Tzannis, Kimon
AU  - Espinosa Montaño, Marta
AU  - Bozionelou, Vasiliki
AU  - Christodoulou, Christos
AU  - Stefanou, Dimitra
AU  - Kalofonos, Haralabos
AU  - Duran, Ignacio
AU  - Papazisis, Konstantinos
PY  - 2017
DO  - 10.2147/OTT.S141260
SN  - 1178-6930
UR  - https://hdl.handle.net/10668/27433
T2  - OncoTargets and therapy
AB  - We aimed to provide real-life data on the outcomes of metastatic renal cell carcinoma (mRCC) patients treated with everolimus as second-line treatment after failure of first-line pazopanib. Data from the medical charts of mRCC patients from 8 centers...
LA  - en
KW  - everolimus
KW  - pazopanib
KW  - renal cell carcinoma
TI  - Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib.
TY  - research article
VL  - 10
ER  -